Search research articles
Contact Us
Filters
Showing results (21-30 of 95) with videos related to
Page
of 10
Sort By:
Breast Cancer Research and Treatment
|
June 1, 2013
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
Roman Rouzier, Paolo Pronzato, Elisabeth Chéreau, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 21, 2009
Sublethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low prosenescent doses of epirubicin: the protective role of dexrazoxane
Paolo Spallarossa, Paola Altieri, Paolo Pronzato, et al.
Healthcare (Basel, Switzerland)
|
January 8, 2025
The Ligurian Experience in the Management of Lung Cancer: Organizational Models and New Perspectives
Daniela Amicizia, Francesca Marchini, Paolo Pronzato, et al.
Tumori
|
June 16, 2020
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)
Antonino C Tralongo, Andrea Antonuzzo, Paolo Pronzato, et al.
Journal of the National Cancer Institute
|
December 27, 2007
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials
Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, et al.
Expert Review of Anticancer Therapy
|
October 18, 2012
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients
Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, et al.
Future Oncology (London, England)
|
April 25, 2020
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy
Marco Danova, Paolo Pronzato, Ylenia Ingrasciotta, et al.
Melanoma Research
|
October 15, 2013
The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival
Stefania Vecchio, Francesco Spagnolo, Domenico F Merlo, et al.
Expert Review of Clinical Pharmacology
|
August 23, 2016
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients
Francesca Poggio, Matteo Lambertini, Eva Blondeaux, et al.
Leukemia Research
|
April 7, 2012
Stevens-Johnson syndrome after treatment with bendamustine
Matteo Lambertini, Lucia Del Mastro, Giovanni Gardin, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 95) with videos related to
Sort By:
Page
of 10
Breast Cancer Research and Treatment
|
June 1, 2013
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
Roman Rouzier, Paolo Pronzato, Elisabeth Chéreau, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 21, 2009
Sublethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low prosenescent doses of epirubicin: the protective role of dexrazoxane
Paolo Spallarossa, Paola Altieri, Paolo Pronzato, et al.
Healthcare (Basel, Switzerland)
|
January 8, 2025
The Ligurian Experience in the Management of Lung Cancer: Organizational Models and New Perspectives
Daniela Amicizia, Francesca Marchini, Paolo Pronzato, et al.
Tumori
|
June 16, 2020
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)
Antonino C Tralongo, Andrea Antonuzzo, Paolo Pronzato, et al.
Journal of the National Cancer Institute
|
December 27, 2007
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials
Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, et al.
Expert Review of Anticancer Therapy
|
October 18, 2012
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients
Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, et al.
Future Oncology (London, England)
|
April 25, 2020
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy
Marco Danova, Paolo Pronzato, Ylenia Ingrasciotta, et al.
Melanoma Research
|
October 15, 2013
The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival
Stefania Vecchio, Francesco Spagnolo, Domenico F Merlo, et al.
Expert Review of Clinical Pharmacology
|
August 23, 2016
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients
Francesca Poggio, Matteo Lambertini, Eva Blondeaux, et al.
Leukemia Research
|
April 7, 2012
Stevens-Johnson syndrome after treatment with bendamustine
Matteo Lambertini, Lucia Del Mastro, Giovanni Gardin, et al.
Page
of 10